Cargando…
Efficacy of Galidesivir against Ebola Virus Disease in Rhesus Monkeys
BACKGROUND: The recent re-emergence of Ebola virus in the Democratic Republic of the Congo serves as a stark reminder of the 2013–2016 Ebola virus (EBOV), which resulted in >11,000 deaths. To date, there are no approved therapeutics or vaccines for EBOV disease (EVD). Galidesivir (BCX4430) is an...
Autores principales: | Warren, Travis, MacLennan, Steve, Mathis, Amanda, Giuliano, Enzo, Taylor, Ray, Sheridan, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632034/ http://dx.doi.org/10.1093/ofid/ofx163.697 |
Ejemplares similares
-
Galidesivir, a Direct-Acting Antiviral Drug, Abrogates Viremia in Rhesus Macaques Challenged with Zika Virus
por: Lim, So-Yon, et al.
Publicado: (2017) -
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus
por: Warren, Travis K., et al.
Publicado: (2021) -
Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters
por: Westover, Jonna B., et al.
Publicado: (2018) -
An update on the progress of galidesivir (BCX4430), a broad-spectrum antiviral
por: Julander, Justin G., et al.
Publicado: (2021) -
Activity of Galidesivir in a Hamster Model of SARS-CoV-2
por: Taylor, Ray, et al.
Publicado: (2021)